ICICI Pru Focused Equity Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

ICICI Pru Focused Equity Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

ICICI Pru Focused Equity Fund - Direct (G)

17.36%

stock2

Nippon India Pharma Fund - Direct (G)

18.23%

Graph not available
Graph not available

About Fund

HDFC Bank Limited

Computer Age Management Services Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

10484.45

1.83

99.92

January 1, 2013

0

Very High Risk

5000

8080.97

1.12

554.7449

January 1, 2013

1

29.89 %

23.14 %

17.36 %

23.47 %

20.59 %

18.23 %

Anish Tawakley

PGDM (MBA) from IIM Bangalore and B. Tech (Mechanical Engineering) from IIT Delhi

Prior joining to ICICI AMC he has worked with Barclays India - Equity Research, Credit Suisse India - Equity research - Indian financial services sector,

Mittul Kalawadia

B.COM from Mithibai College, M.COM. frpm University of Mumbai and CA. from ICAI.

He has over 10 years of experience in fund management/Investment analyst role. He is associated with ICICI Prudential Asset Management Company Limited from January 2006 till date. Past Experience: ICICI Prudential Asset Management Company Limited - Equity Research Analyst - October 2008 till February 2012. ICICI Prudential Asset Management Company Limited - Business Planning & MIS - January 2006 to September 2008.

Mrinal Singh

BE (Mech), PGDM (SPJIMR - Mumbai)

He has an overall experience of around 16 years. He is associated with ICICI Prudential Asset Management Company Limited since June 2008. Past Experience: Wipro Ltd - IT Services - May 2005 to May 2008. BOSCH India (erstwhile MICO) - R&D - October 2000 to June 2003.

Prakash Gaurav Goel

Chartered Accountant and Bachelor or Commerce

Overall experience of 14 years in investment related activities. 2008-till September 20, 2017 - Vice President, Equity Research ICICI Securities Limited. 2006-2008-Research-Manager, IREVNA Research. 2003-2006-Commercial Manager, Hindustan Unilever.

Sankaran Naren

B.Tech - IIT Madras, PGDM, IIM Calcutta

Prior to joining ICICI Prudential AMC, he has worked with various financial services companies like Refco Sify securities India Pvt. ltd., HDFC Securities Ltd. and Yoha Securities in Various Positions.

Vaibhav Dusad

MBA, B.Tech, M.Tech, IIT Chennai

Mr. Vaibhav Dusad has around 11 years of experience in field of investment analysis. Currently, he is a senior investment analyst and a fund manager Past Experience: Morgan Stanley - Research Analyst - June 2014 to December 2017. HSBC - Research Analyst - November 2011 to April 2013. Crisil Irevna - Research Analyst- October 2010 to October 2011. Zinnov - Research Analyst - October 2009 to September 2010.

Vinay Sharma

MBA., CFA

Prior to joining Reliance Mutual Fund (April 2018 till date) he was associated with ICICI Prudential AMC in 2012 he has worked with AIG Global Asset Managment India Ltd. and J.P.Morgan India Pvt.Ltd.

Yogesh Bhatt

CA, ICWAI

Prior joining Pru AMC, he had been with sushil Finance Consultants Ltd. for 10 years as equity dealer and for the next 3 years he was with Falcon Brokerage P Ltd.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right

When comparing ICICI Pru Focused Equity Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both ICICI Pru Focused Equity Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing ICICI Pru Focused Equity Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between ICICI Pru Focused Equity Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare ICICI Pru Focused Equity Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions